Drimia calcarata鳞茎提取物抑制宫颈HPV-18阳性HeLa细胞的PI3K信号通路
DOI:
作者:
作者单位:

Department of Biochemistry, Microbiology and Biotechnology, University of Limpopo, Private Bag X1106, Sovenga 0727, Polokwane, South Africa

作者简介:

通讯作者:

中图分类号:

基金项目:


Drimia calcarata Bulb Extracts Deactivate the PI3K Signalling Pathway in Cervical HPV-18 Positive HeLa Cells
Author:
Affiliation:

Department of Biochemistry, Microbiology and Biotechnology, University of Limpopo, Private Bag X1106, Sovenga 0727, Polokwane, South Africa

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    背景:Drimia Calcarata治疗人类宫颈癌的功效尚未得到充分探索,缺乏深入理解。目的:本研究聚焦探索D. calcarata鳞茎提取物对宫颈癌细胞的细胞毒作用。方法:采用MTT法、Ki67细胞增殖检测和PI3K 激活试验测定D. calcarata提取物对细胞的生长抑制作用。使用荧光显微镜、Muse?细胞分析仪评估对细胞凋亡的诱导能力,通过RT-PCR分析基因表达。甲醇提取物(ME)和水提物(WE)对KMST-6和HEK-293两种非癌细胞均安全无毒,对HeLa细胞具有抗肿瘤活性,而对Ca-Ski宫颈癌上皮细胞无明显细胞毒性。结果:WE增加Ki67阳性Ca-Ski细胞群,ME和WE均能将HeLa细胞和Ca-Ski 细胞分别阻滞于G2/M期和G0/G1期。AO/EB荧光染色、膜联蛋白annexin V和caspase 3/7激活实验显示,两种提取物均能显著诱导HeLa细胞凋亡。HeLa细胞中,ME下调突变型TP53表达,而WE上调两种突变型TP53表达。两种提取物均下调HeLa细胞中STAT5A和STAT5B mRNA水平表达,但在Ca-Ski中二者上调促癌基因STAT3表达。此外,这些提取物均能使HeLa细胞而非Ca-Ski细胞的PI3K信号通路失活。Ca-Ski细胞对D. calcarata提取物的抗性可能是由于STAT3上调和PI3K信号通路激活。D. calcarata提取物对HeLa细胞的细胞毒性和促凋亡作用可能是由于下调STAT5A相关的细胞生存机制。水提组分1号、2号、3号、6号和醇提组分1号、2号均降低HeLa细胞活力。水提组分2号、3号、6号和醇提组分1号、3号诱导细胞凋亡,并继发坏死。但1号水提组分和2号醇提组分致多数细胞坏死。鉴于几种组分显示对HeLa细胞的细胞毒性,水提物和醇提物中的若干化合物可认为具有抗肿瘤活性。结论:以上发现提示D. calcarata提取物具有抗肿瘤活性,可能对HPV-18阳性妇科恶性肿瘤具有抗癌疗效。

    Abstract:

    Background The efficacy of Drimia calcarata against the human cervical cancer remains unexplored and less understood. Objective The present study focused on investigating the cytotoxic effect of D. calcarata bulb extracts on cervical cancer cells. Methods The growth inhibitory effects of D. calcarata extracts were determined using the MTT, Ki67 and PI3K Activation assays. Apoptosis induction was assessed using fluorescence microscopy, the Muse? Cell Analyser and gene expression analysis by RT-PCR. The cytotoxicity of the fractions was evaluated using MTT assay and the apoptosis induction using Muse? Cell Analyser. Results Both methanol extract (ME) and water extract (WE) showed safety against noncancerous KMST-6 and HEK-293 cells. The extracts exhibited anticancer activity against HeLa, with no significant cytotoxic effect against the Ca-Ski cells. The WE increased the Ki67 positive Ca-Ski population, while both ME and WE arrested HeLa cells at G2/M phase, and Ca-Ski cells in G0/G1 phase. AO/EB staining, Annexin V and Caspase 3/7 Activation revealed that the extracts significantly induced apoptosis in HeLa cells. In HeLa cells, the ME downregulated TP53 variants, while WE upregulated both TP53 variants in HeLa cells. Both extracts decreased the STAT5A and STAT5B mRNA expression in HeLa cells; however, these extracts upregulated cancer-promoting STAT3 in Ca-Ski cells. Additionally, these extracts inactivated the PI3K signalling pathway in HeLa cells but not in Ca-Ski cells. The resistance of the Ca-Ski cells to the D. calcarata extracts may be due to the upregulation of STAT3 and activated PI3K signalling pathway. The cytotoxicity and apoptosis induction in HeLa cells by D. calcarata extracts may be attributed to downregulation of STAT5A survival mechanisms. Water fractions 1, 2, 3 and 6 and methanol fractions 1 and 2 reduced cell viability of HeLa cells. Water fractions 2, 3 and 6 and methanol fractions 1 and 3 induced apoptosis, which was preceded by secondary necrosis. However, water fraction 1 and methanol fraction 2 led to most cells undergoing necrotic cell death. There are several compounds that can be credited with the anticancer activities of the ME and WE extracts since several fractions exhibited cytotoxicity against the HeLa cells. Conclusion These findings suggest that the D. calcarata extracts have anticancer activities, and thus, could be useful for therapeutic purposes against human HPV-18 positive gynaecologic cancers.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-11-24
  • 出版日期: